新型香豆素类衍生物的合成及抗肿瘤活性研究

为了寻找结构新颖、活性较好的抗肿瘤化合物,设计合成了19个未见文献报道的3,4,5-三甲氧基苯基香豆素类化合物,并用核磁共振(NMR)和高分辨质谱(HRMS)等方法对化合物结构进行表征.用四甲基偶氮唑盐(MTT)法评价了该类化合物对人前列腺癌细胞(PC-3)、人食管癌细胞(EC-109)和人胃癌细胞(MGC-803)三种肿瘤细胞的抑制活性.结果显示,N-苄基-2-((4-甲基-2H-色烯-2-酮-7-基)氧基)-N-(3,4,5-三甲氧基苯基)乙酰胺(4a)和N-((5-氯苯并[b]噻吩-3-基)甲基)-2-((4-甲基-2H-色烯-2-酮-7-基)氧基)-N-(3,4,5-三甲氧基苯基)乙酰胺(4n)对三种肿瘤细胞的抑制活性优于阳性对照药5-氟尿嘧啶,其中化合物4n对人前列腺癌细胞(PC-3)的抑制活性最好,其IC_(50)为4.18μmol/L.     

含喹唑啉酮的查尔酮衍生物的设计、合成及生物活性研究

设计合成了25个含喹唑啉酮的查尔酮衍生物.抗病毒生物实验结果表明,(E)-3-(4-氯苯基)-6-氟-2-((2-(4-(3-(4-甲氧基苯基)丙烯酰基)苯氧基)乙基)硫代)喹唑啉-4(3H)-酮(Z12)对烟草花叶病毒(tobacco mosaic virus, TMV)有较好的抑制活性,治疗和保护的EC50值分别为94.3和98.8μg/mL,优于对照药宁南霉素(ningnanmycin,NNM)的216.1和189.6μg/mL.透射电镜结果表明,Z12使得TMV病毒颗粒断裂,形成长短不一的棒状结构,微量热涌动实验(MST)的结果表明, Z12对烟草花叶病毒外壳蛋白(TMV-CP)结合的Kd值为(0.033±0.014)μmol/L,优于宁南霉素的Kd值[(0.106±0.024)μmol/L],说明了Z12对TMV-CP具有更强的结合力.抑菌实验结果表明,部分化合物对水稻白叶枯病菌(Xanthomonas oryzae pv. Oryzae, Xoo)和柑桔溃疡病菌(Xanthomonas axonopodis pv. Citri, Xac)表现出优异活性,其中(E)-2-((...     

含苯并咪唑的2,4-取代喹唑啉衍生物的合成及抗肿瘤活性评价（英文）

为了寻找高效的抗肿瘤药物,设计并合成了一系列新型的2,4-取代喹唑啉类衍生物,采用噻唑蓝(MTT)法对目标化合物在人类胃癌细胞(MGC-803)、乳腺癌细胞(MCF-7)和人正常胃黏膜上皮细胞GES-1进行抗肿瘤活性评价,结果显示部分化合物对MGC-803和MCF-7表现出中度至强效的抗肿瘤活性.喹唑啉的4位被不同芳胺取代时,2-(((1H-苯并[d]咪唑-2-基)甲基)硫基)-N-(4-甲氧基苯基)喹唑啉-4-胺(15e)对MGC-803具有较好的抗肿瘤活性,IC50值为4.60μmol·L-1;喹唑啉的4位被不同查尔酮取代时,(E)-1-(4-((2-(((1H-苯并[d]咪唑-2-基)甲基)硫基)喹唑啉-4-基)氨基)苯基)-3-(3-硝基苯基)丙-2-烯-1-酮(15k)对MGC-803具有很强的抗肿瘤活性, IC50值为0.97μmol·L-1,明显优于化合物15e.但是化合物15e对GES-1的毒性远远大于化合物15k,化合物15k的毒性与对照药品5-氟尿嘧啶和吉非替尼相近.分子对接结果显示,化合物15k与表皮生长因子受体(EGFR)的结合模式优于15e,为研究新型的EGFR抑制剂提供了新的思路.     

新型含4-苯基-5-硫亚基-1,2,4-三唑曼尼希碱的喹唑啉酮类衍生物的设计合成及其生物活性研究

以喹唑啉-4-酮为起始原料,经五步反应合成了9个新型的含4-苯基-5-硫亚基-1,2,4-三唑曼尼希碱的喹唑啉酮类衍生物6a~6i,通过1H NMR、13C NMR、IR和元素分析对它们的结构进行了表征,并用X射线单晶衍射法测定了3-[(1-吗啉甲基-4-苯基-5-硫亚基-4,5-二氢-1H-1,2,4-三唑-3-基)甲基]喹唑啉-4(3H)-酮(6e)的晶体结构.初步生物活性测试结果表明,绝大部分该类化合物在200μg/m L浓度下对水稻白叶枯病菌和柑橘溃疡病菌都表现出了优良的抑制活性;在50μg/m L浓度下该类化合物对所测六种真菌都具有一定的抑制活性.     

新型4-氨基喹唑啉衍生物的合成及其抗肿瘤活性

以香草醛为起始原料,与1-溴-3-氯丙烷经烷基化反应后,再与盐酸羟胺反应制得4-(3-氯丙氧基)-3-甲氧基苯腈(3);3经硝酸硝化、铁粉还原后,与N,N-二甲基甲酰胺二甲缩醛反应制得N-[5-(3-氯丙氧基)]-2-腈基-4-甲氧基苯基-N,N-二甲基甲酰胺(6);6与3-氯-4-氟苯胺合环后与芳香醚经取代反应合成了7个新型的4-氨基喹唑啉衍生物(9a~9g),其结构经1H NMR,13C NMR,IR和元素分析表征。初步生物活性测定结果表明:在用药量为10μmol·L-1时,N-(3-氯-4-氟苯基)-7-[3-(2-氯基苯氧基)丙氧基]-6-甲氧基喹唑啉-4-胺(9d)和5-氯-2-【3-{4-[(3-氯-4-氟苯基)胺]-6-甲氧基喹唑啉}-7-氧丙氧基】苯甲醛(9g)对人乳腺癌细胞Bcap-37的抑制率分别为61.4%和78.9%。     

新型二唑类4-氨基喹唑啉衍生物的合成及其抗肿瘤活性

N-(3-氯-4-氟苯胺基)-7-(3-氯丙氧基)-6-甲氧基喹唑啉-4-胺与一系列取代二唑类化合物经取代反应合成了6个新型的二唑类4-氨基喹唑啉衍生物(3a~3f),其结构经1H NMR,13C NMR,IR及元素分析表征。用MTT法初步测定了3a~3f对前列腺癌细胞(PC-3)和人乳癌细胞(Bcap-37)的抑制率。结果表明:N-(3-氯-4-氟苯基)-6-甲氧基-7-{3-[5-(4-硝基苯基)-1,3,4-噻二唑-2-巯基]丙氧基}喹唑啉-4-胺和N-(3-氯-4-氟苯基)-7-{3-[5-(4-氯苯基)-1,3,4-噁二唑-2-巯基]丙氧基}-6-甲氧基喹唑啉-4-胺在用药量为10μmol·L-1时对PC-3的抑制率分别为66.8%和72.2%。     

N-(1,2,4-三唑)含氟肉桂醛亚胺的合成及生物活性

含氟肉桂醛与4-氨基-5-(3,4,5-三甲氧基苯基)-1,2,4-三唑-3-硫酮(2)缩合生成5-(3,4,5-三甲氧基苯基)-4-取代苯基烯丙亚胺基-1,2,4-三唑-3-硫酮(3),再烷基化为新型含氟肉桂醛1,2,4-三唑亚胺(4).化合物结构经1HNMR,13CNMR,IR以及元素分析确认,并用X-ray单晶衍射测定了化合物4g的晶体结构,证实了分子中两个环外双键N=C和C=C均为E-式构型.初步生物活性测试结果表明,部分化合物具有抗植物病毒活性.     

含喹唑啉-4-酮片段的新型1,2,4-三唑酰腙类衍生物的合成及抗菌活性

通过三唑酰肼和芳醛的缩合反应,合成了20个含喹唑啉酮-4-酮片段的新型1,2,4-三唑酰腙类化合物,利用核磁共振氢谱、碳谱和高分辨质谱对它们的结构进行了表征.体外抗菌测试表明,绝大部分目标化合物对水稻白叶枯病菌和柑橘溃疡病菌都表现出良好的抑制活性,其中N'-(2-甲氧基亚苄基)-1-(2-(4-氧代喹唑啉-3(4H)-基)乙基)-1H-1,2,4-三唑-3-酰腙(7q)在100μg/m L下对上述两种病菌的抑制率均达100%.此外,1-(2-(4-氧代喹唑啉-3(4H)-基)乙基)-N'-(4-(三氟甲基)亚苄基)-1H-1,2,4-三唑-3-酰腙(7i)、N'-(2-溴亚苄基)-1-(2-(4-氧代喹唑啉-3(4H)-基)乙基)-1H-1,2,4-三唑-3-酰腙(7j)、N'-(4-溴亚苄基)-1-(2-(4-氧代喹唑啉-3(4H)-基)乙基)-1H-1,2,4-三唑-3-酰腙(7l)和N'-(4-甲基亚苄基)-1-(2-(4-氧代喹唑啉-3(4H)-基)乙基)-1H-1,2,4-三唑-3-酰腙(7o)在50μg/m L下对番茄灰霉病菌的抑制率均超过55%.     

含硫醚三唑的1,4-戊二烯-3-酮衍生物合成及生物活性研究

将含硫醇的三唑引入到1,4-戊二烯-3-酮结构中,合成一系列含硫醚三唑的1,4-戊二烯-3-酮类衍生物,其结构通过~1H NMR、~(13)C NMR、HRMS进行表征.生物活性测试结果表明:目标化合物对柑橘溃疡病菌(X. citri)、水稻白叶枯病菌(X. oryzae)、烟草青枯病菌(R. solanacearum)都表现出一定的抑制活性.其中,化合物F_4、F_6、F_(16)对柑橘溃疡病菌的EC_(50)值分别为16.3、9.9、15.9μg/mL,优于对照药叶枯唑(54.9μg/mL);化合物F_1、F_7、F_(15)对水稻白叶枯病菌的EC_(50)值分别为9.6、19.2、21.3μg/mL,优于对照药叶枯唑(69.3μg/mL);化合物F3、F6对烟草青枯病菌的EC_(50)值分别为14.2、14.5μg/mL,优于对照药叶枯唑(82.6μg/m L).通过扫描电镜成像探讨了目标化合物F6对柑橘溃疡病菌(X.Citri)的可能抑菌机制.     

含三氟甲基吡啶结构的酰胺类衍生物的合成、表征及生物活性研究（英文）

合成了一系列含三氟甲基吡啶结构的酰胺衍生物,并测试了它们对水稻白叶枯病菌(Xanthomonas oryzae pv.oryzae)、柑橘溃疡病菌(Xanthomonas axonopodis pv.citri)、烟草青枯病菌(Ralstonia solanacearum)的体外抑菌活性和对小菜蛾(Plutella xylostella)的杀虫活性.结果表明,部分化合物表现出优异的抑菌活性.如2-((3-氯-5-(三氟甲基)吡啶-2-基)氧基)-N-(4-氟-2-甲基苯基)乙酰胺(6d)对水稻白叶枯病菌的EC_(50)值为54.1 mg·L~(-1),低于叶枯唑(EC_(50)=59.6 mg·L~(-1))和噻菌酮(EC_(50)=86.3 mg·L~(-1)).2-((3-氯-5-(三氟甲基)吡啶-2-基)氧基)-N-(4-氟-3(三氟甲基)苯基)乙酰胺(6h)和2-((3-氯-5-(三氟甲基)吡啶-2-基)氧基)-N-(5,6-二氯吡啶-3-基)乙酰胺(6z)对柑橘溃疡病菌的抑制活性(EC_(50)值为51.2和60.7 mg·L~(-1))均高于商品药剂叶枯唑(EC_(50)=76.3 mg·L~(-1))和噻菌酮(EC_(50)=101.7 mg·L~(-1)).N-(2-氯-4-氟苯基)-2-((3-氯-5-(三氟甲基)吡啶-2-基)氧基)乙酰胺(6e)对烟草青枯病菌的抑菌活性略高于噻菌酮(EC_(50)=79.0 mg·L~(-1)),EC_(50)值为74.9 mg·L~(-1).此外,化合物6e和2-((3-氯-5-(三氟甲基)吡啶-2-基)氧基)-N-(3-异丙基苯基)乙酰胺(6k)在浓度为500 mg·L~(-1)时表现出中等程度的杀小菜蛾活性.     

Design,synthesis, biological activity evaluation and mechanism of action of myricetin derivatives containing thioether quinazolinone

Plant bacteria and viruses have a huge negative impact on food crops in the world. Therefore, it is important to create new and efficient green pesticides. In this paper, a series of myricetin derivatives containing quinazolinone sulfide were introduced. Good antibacterial and antiviral activities of the drug molecules 2-((3-((5,7-dimethoxy-4-oxo-2-(3,4,5-trimethoxyphenyl)-4H-chromen-3-yl)oxy)propyl)thio)-6-fluoro-3-phenylquinazolin-4(3H)-one (T5) and 2-((4-((5,7-dimethoxy-4-oxo-2-(3,4,5-trimethoxyphenyl)-4H-chromen-3-yl)oxy)butyl)thio)-6-methyl-3-phenylquinazolin-4(3H)-one (T15) respectively were found by biological activity screening. The value of dissociation constant (K_d) of compound T15 to TMV CP was 0.024 ± 0.006 μM, determined by Microscale thermophoresis (MST), which was far less than the value of 8.491 ± 2.027 μM of commercial drug ningnanmycin (NNM). The interaction between compound T15 and TMV CP was further verified by molecular docking. Compound T15 formed strong hydrogen bonds with residues SER:49 and SER:15 (1.92 Å, 2.20 Å, respectively), which were superior to the traditional hydrogen bonds formed by NNM with residue SER:215 (3.64 Å). In addition, the effects of compound T15 on the contents of chlorophyll and peroxidase (POD) in tobacco were studied, and the results indicated that compound T15 could enhance the disease resistance of tobacco plants to a certain extent.     

新型1-(4-取代苯基)-3-[4-(4-氧香豆素基)苯基]硫脲衍生物的合成及其抑菌活性

以4-羟基香豆素为原料,经氯化、醚化和异硫氰酸化3步反应制得中间体——4-(4-异硫氰酸酯苯氧基)香豆素(3);3与取代芳香胺经加成反应合成了9个新型的1-(4-取代苯基)-3-[4-(4-氧香豆素基)苯基]硫脲衍生物(4a~4i),其结构经1H NMR,13C NMR,IR和MS(ESI)表征。采用浑浊度法测试了4的抑菌活性。结果表明:4a、4b、4e和4f抑制烟草青枯菌活性EC50值分别为112.02、121.39、88.72和86.90μg·mL~(-1),优于噻菌铜(130.25μg·mL~(-1));4a、4b、4e和4f抑制番茄青枯菌活性EC50值分别为107.89、110.69、82.43和82.48μg·mL~(-1),优于噻菌铜(123.94μg·mL~(-1))。     

X-Ray Diffraction Study of 8-(Pyridin-2-yl)- and 8-(1,2,4-Triazin-5-yl)-2H-chromen-2-ones

Russian Journal of General Chemistry - The molecular and crystal structures of 8-(3,6-diphenylpyridin-2-yl)-5,7-dimethoxy-4-phenyl-2H-chromen-2-one,...     

Synthesis of a capillarisin sulfur-analogue possessing aldose reductase inhibitory activity by selective isopropylation

We describe the synthesis of 2-[(4-hydroxyphenyl)thio]-7-isopropoxy-5,6-dimethoxy-4H-chromen-4-one 2 from 3,4,5-trimethoxyphenol 6 via the key intermediate, 3-iodo-7-isopropoxy-5,6-dimethoxy-4H-chromen-4-one 3. An important feature of this synthetic scheme involves selective alkylation, which can be achieved by two different routes. One route involves the selective isopropylation of a triacetate derivative 4 under basic conditions. The second route employs the selective demethylation of a trimethoxy derivative 5 under acidic conditions followed by isopropylation. The product of these alternative routes, compound 3, is then converted to a capillarisin sulfur analogue 2 in a one-pot reaction via the imidazolyl intermediate 22.     

1-芳基-3-(3-(4-氧香豆素基)苯基)硫脲衍生物的合成及抑菌活性

为了筛选出具有较高抑菌活性的含香豆素的硫脲类衍生物,本文以4-羟基香豆素为原料,经氯化、醚化、异硫氰酸化和加成反应合成了一系列1-芳基-3-(3-(4-氧香豆素基)苯基)硫脲衍生物,其结构经红外光谱(IR)、核磁共振谱(NMR)和质谱(MS)等技术手段进行了表征。结果表明,目标化合物对水稻白叶枯菌和柑橘溃疡菌均具有较好的抑制活性。其中化合物4k、4l、4m和4n抑制水稻白叶枯菌活性EC_(50)值分别为137.42、131.05、129.23和117.43 mg/L,优于对照药剂噻菌铜的活性(195.24 mg/L);化合物4k、4l、4m和4n抑制柑橘溃疡菌活性EC_(50)值分别为97.02、94.31、102.28和90.52 mg/L,优于噻菌铜的活性(120.25 mg/L)。     

Synthesis and biological activities of benzothiazole derivatives bearing a 1,3,4-thiadiazole moiety

A series of benzothiazole derivatives bearing a 1,3,4-thiadiazole moiety were designed, synthesized and evaluated for their antibacterial, antifungal and antiviral activities. The bioassay results indicated that most of target compounds showed good antiviral activities against tobacco mosaic virus (TMV) and antibacterial activities against Xanthomonas oryzae pv. oryzae (Xoo) and Ralstonia solanacearum (Rs). Especially, the anti-Xoo effect of title compounds 5k (N-(5-methoxybenzo[d]thiazol-2-yl)-2-((5-(2-tolyl)-1,3,4-thiadiazol-2-yl)thio)acetamide) and the anti-Rs effect of title compounds 5a (N-(5-nitrobenzo[d]thiazol-2-yl)-2-((5-(4-(trifluorom ethyl)phenyl)-1,3,4-thiadiazol-2-yl)thio)acetmide) respectively reached 52.4% and 71.6% at 100?µg/mL, which are superior to that of bismerthiazol (32.0% and 52.3%). In addition, the protective and inactivation activities of title compound 5i (N-(5-methoxybenzo [d]thiazol-2-yl)-2-((5-(4-nitrophenyl)-1,3,4-thiadiazol-2-yl)thio)acetamide) against TMV were 79.5% and 88.3%, respectively, which are better than that of ningnanmycin (76.4% and 86.8%). The above research showed that benzothiazole derivatives bearing a 1,3,4-thiadiazole moiety may be used as potential molecular templates in searching for highly-efficient antiviral and antibacterial agents.     

三唑类白杨素衍生物的设计、合成及其抗增殖活性研究

合成了2个系列的白杨素衍生物,采用噻唑蓝(MTT)法测试了所有化合物针对六种肿瘤细胞的体外抗增殖活性,包括MGC-803, BEL-7402, HepG2, HeLa, A549以及SGC-7901细胞.实验结果显示, 7-[1-(3-氟苯基)-1H-1,2,3-三唑-4-甲氧基]-白杨素(1c)与7-[1-(2-氯苯基)-1H-1,2,3-三唑-4-甲氧基]-白杨素(1g)针对MGC-803细胞的活性与先导化合物白杨素及阳性对照药5-氟尿嘧啶相比显著提高.因此,化合物1c与1g具有深入研究用以开发抗癌药物的潜能.     

Synthesis and biological activities of novel quinazolinone derivatives containing a 1,2,4-triazolylthioether moiety

A series of novel quinazolinone derivatives containing a 1,2,4-triazolylthioether moiety were synthesised and their antimicrobial activities were evaluated. All the target compounds were characterised by ¹H NMR, ¹³C NMR, ESI-MS, IR and elemental analyses. The single crystal structure of 3-((5-((2-fluorobenzyl)thio)-4-phenyl-4H-1,2,4-triazol-3-yl)methyl)quinazolin-4(3H)-one (VIIi) was also determined. The preliminary bioassays indicated that some of the target compounds possessed good antimicrobial activities. For example, 3-((4-phenyl-5-((4-(trifluoromethyl)benzyl)thio)-4H-1,2,4-triazol-3-yl)methyl)quinazolin-4(3H)-one (VIIs) exhibited the best inhibitory effect against Xanthomonas oryzae pv. oryzae and Xanthomonas axonopodis pv. citri with the half-effective concentration (EC₅₀) values of 47.6 μg mL^?1 and 22.1 μg mL^?1, respectively, which were superior to the commercial bactericide, bismerthiazol. Meanwhile, 3-((5-((4-chlorobenzyl)thio)-4-phenyl-4H-1,2,4-triazol-3-yl)methyl)quinazolin-4(3H)-one (VIIh) exhibited better fungicidal activities against Pellicularia sasakii and Colletotrichum capsici at the concentration of 50 μg mL^?1, in comparison with the commercial fungicide, hymexazol.     

Synthesis and nematicidal activities of 1,2,3-benzotriazin-4-one containing 4,5-dihydrothiazole-2-thiol derivatives against Meloidogyne incognita

Abstract

A series of novel 1,2,3-benzotriazin-4-one derivatives containing 4,5-dihydrothiazole-2-thiol were synthesized and characterized by ¹H NMR, ¹³C NMR, ¹⁹F NMR and HRMS. The bioassay results showed that compounds 3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)-7-methoxybenzo[d][1–3]triazin-4(3H)-one, 3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)-6-nitrobenzo[d][1–3]triazin-4(3H)-one, 7-chloro-3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)benzo[d][1–3]triazin-4(3H)-one exhibited good control efficacy against the cucumber root-knot nematode disease caused by Meloidogyne incognita at the concentration of 10.0?mg L^?1 in vivo. Compound 7-chloro-3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)benzo[d][1–3]triazin-4(3H)-one showed excellent nematicidal activity with inhibition 68.3% at a concentration of 1.0?mg L^?1. It suggested that the structure of 1,2,3-benzotriazin-4-one containing 4,5-dihydro-thiazole-2-thiol could be optimized further.